Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Takeda claims bicyclic compounds for micturition disorders

April 6, 1998

Dual-action agent for BPH developed at Zeria

April 3, 1998

N-Alkylated saccharins from Merck & Co. with potential in BPH therapy

April 2, 1998

FDA approves DDAVP tablets for nocturnal enuresis in children

April 1, 1998

New vasopressin antagonist from JT with aquaretic effects in animals

April 1, 1998

Detrol approved by FDA for overactive bladder

March 30, 1998

Synaptic licenses technology for BPH treatment to Glaxo Wellcome

March 25, 1998

Genetic basis for congenital kidney disease pinpointed by BioStratum scientists

March 23, 1998

Taiwan researchers identify lead potassium channel opener selective for bladder

March 18, 1998

Use of aspirin to prevent preeclampsia should be discontinued, NIH researchers say

March 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...